Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Abstract

Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.

R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
Molecular Pharmacology June 1996, 49 (6) 972-979;
R Danesi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Nardini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Basolo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Del Tacca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Samid
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C E Myers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 49 no. 6 972-979
PubMed 
8649357

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online June 1, 1996.


Author Information

  1. R Danesi,
  2. D Nardini,
  3. F Basolo,
  4. M Del Tacca,
  5. D Samid and
  6. C E Myers
  1. Scuola Superiore di Studi Universitari e di Perfezionamento S. Anna, Università di Pisa, Italy. mbxdanesi@mail.cnuce.cnr.it

    Statistics from Altmetric.com

    Article usage

    Article usage: January 1999 to July 2022

    AbstractFullPdf
    Jan 1999100
    Mar 1999100
    May 1999200
    Jun 1999200
    Jul 1999100
    Sep 1999100
    Oct 2000100
    Mar 2001200
    Apr 2001100
    May 2001100
    Aug 2001100
    Oct 2001300
    Nov 2001100
    Dec 2001200
    Jan 2002300
    Feb 2002100
    Mar 2002100
    May 2002100
    Aug 2002100
    Oct 2002100
    Nov 2002200
    Jan 2003100
    Mar 2003100
    Apr 2003100
    May 2003100
    Jun 2003100
    Jul 2003500
    Aug 2003400
    Sep 2003900
    Oct 2003300
    Nov 2003600
    Dec 20031100
    Jan 20041200
    Feb 2004400
    Mar 2004500
    Apr 2004300
    May 2004400
    Jun 2004700
    Jul 20041100
    Aug 2004500
    Sep 2004400
    Oct 2004300
    Nov 2004500
    Dec 2004300
    Jan 20051100
    Feb 2005400
    Mar 2005800
    Apr 2005300
    May 2005300
    Jun 2005300
    Jul 2005202
    Aug 2005201
    Sep 2005100
    Oct 2005300
    Nov 2005500
    Jan 2006501
    Feb 2006701
    Mar 2006601
    Apr 2006401
    May 2006100
    Jun 2006100
    Jul 2006301
    Aug 2006200
    Sep 2006100
    Oct 2006300
    Nov 2006403
    Dec 2006302
    Jan 2007406
    Feb 2007201
    Mar 2007502
    Apr 2007201
    May 2007400
    Jun 2007002
    Aug 2007301
    Sep 2007201
    Oct 2007003
    Nov 2007204
    Dec 2007200
    Jan 2008301
    Feb 2008303
    Mar 2008200
    Apr 2008102
    May 2008401
    Jun 2008603
    Aug 2008200
    Sep 2008604
    Oct 2008201
    Nov 2008102
    Dec 2008401
    Jan 2009300
    Mar 2009301
    Apr 2009501
    May 2009401
    Jun 2009201
    Jul 2009504
    Aug 2009300
    Sep 2009700
    Oct 2009600
    Nov 2009500
    Dec 2009301
    Jan 2010300
    Feb 2010401
    Mar 2010804
    Apr 2010607
    Jun 2010503
    Jul 2010400
    Aug 2010802
    Sep 2010200
    Oct 2010701
    Nov 2010300
    Dec 2010600
    Jan 2011600
    Feb 20111306
    Mar 2011902
    Apr 2011700
    May 2011700
    Jun 2011400
    Jul 2011600
    Aug 2011903
    Sep 2011400
    Oct 2011801
    Nov 2011900
    Dec 2011600
    Jan 2012500
    Feb 2012700
    Mar 2012606
    Apr 2012501
    May 2012501
    Jun 2012601
    Jul 2012400
    Aug 2012500
    Sep 2012400
    Oct 2012301
    Nov 2012402
    Dec 2012102
    Jan 2013701
    Feb 2013200
    Mar 2013300
    Apr 2013901
    May 2013301
    Jun 2013202
    Jul 2013501
    Aug 2013200
    Sep 2013300
    Oct 2013300
    Nov 2013201
    Dec 2013301
    Jan 2014602
    Feb 2014402
    Mar 2014101
    Apr 2014302
    May 2014200
    Jun 2014500
    Jul 2014101
    Aug 2014302
    Oct 2014600
    Nov 2014800
    Dec 2014701
    Jan 2015200
    Feb 2015100
    Mar 2015301
    Apr 2015601
    May 2015300
    Jun 2015300
    Jul 2015502
    Aug 2015100
    Sep 2015200
    Oct 2015300
    Nov 2015102
    Dec 2015204
    Jan 2016102
    Feb 2016600
    Mar 2016601
    Apr 2016001
    May 2016100
    Jun 2016301
    Jul 2016300
    Aug 2016100
    Oct 2016202
    Nov 2016601
    Jan 2017300
    Feb 2017200
    Mar 2017300
    May 2017600
    Jun 2017200
    Jul 2017200
    Aug 20171100
    Sep 2017600
    Oct 20171601
    Nov 20171400
    Dec 2017800
    Jan 2018500
    Feb 2018800
    Mar 2018900
    Apr 20181401
    May 2018800
    Jun 2018300
    Jul 2018801
    Aug 2018200
    Sep 2018500
    Oct 2018800
    Nov 2018500
    Dec 2018701
    Jan 2019500
    Feb 20191000
    Mar 2019501
    Apr 2019500
    May 2019403
    Jun 2019801
    Jul 2019800
    Aug 2019704
    Sep 2019801
    Oct 2019500
    Nov 2019800
    Dec 2019700
    Jan 2020400
    Feb 2020600
    Mar 2020500
    Apr 2020100
    May 2020201
    Jul 2020100
    Aug 2020100
    Oct 2020600
    Nov 2020400
    Dec 2020300
    Jan 2021600
    Feb 2021801
    Mar 20211000
    Apr 2021500
    May 20211800
    Jun 20211002
    Jul 20211800
    Aug 20211700
    Sep 2021600
    Oct 2021500
    Nov 20211700
    Dec 2021400
    Jan 20222001
    Feb 2022500
    Mar 2022400
    Apr 2022400
    May 2022400
    Jun 2022800
    Jul 2022300

    PreviousNext
    Back to top

    In this issue

    Molecular Pharmacology
    Vol. 49, Issue 6
    1 Jun 1996
    • Table of Contents
    • Table of Contents (PDF)
    • Index by author
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Molecular Pharmacology article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
    (Your Name) has forwarded a page to you from Molecular Pharmacology
    (Your Name) thought you would be interested in this article in Molecular Pharmacology.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Abstract

    Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.

    R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
    Molecular Pharmacology June 1, 1996, 49 (6) 972-979;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Abstract

    Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.

    R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
    Molecular Pharmacology June 1, 1996, 49 (6) 972-979;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About Molecular Pharmacology
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0111 (Online)

    Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics